Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis

NCT00282425 is registered in ClinicalTrials.gov with Richard Burt, MD as lead sponsor.

NCT NCT00282425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00282425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Lead sponsor
Richard Burt, MD
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2005
Completion date
December 31, 2012
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma